Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R.
J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174.
Pituitary apoplexy: managing the life-threatening condition associated with pituitary adenomas.
Witek P.
Minerva Endocrinol. 2014 Dec;39(4):245-59. Epub 2014 Jul 29.
Antigestogens.
Baird DT.
Br Med Bull. 1993 Jan;49(1):73-87. doi: 10.1093/oxfordjournals.bmb.a072607.
Multiple Endocrine Neoplasia Type 1.
Giusti F, Marini F, Brandi ML.
2005 Aug 31 [updated 2022 Mar 10]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Fertility issues in aggressive pituitary tumors.
Marques JVO, Boguszewski CL.
Rev Endocr Metab Disord. 2020 Jun;21(2):225-233. doi: 10.1007/s11154-019-09530-y.
Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
Koizumi K, Aono T.
Fertil Steril. 1986 Aug;46(2):312-4. doi: 10.1016/s0015-0282(16)49531-2.
[Prolactinoma].
Glezer A, Bronstein MD.
Arq Bras Endocrinol Metabol. 2014 Mar;58(2):118-23. doi: 10.1590/0004-2730000002961.
Norethynodrel.
[No authors listed]
IARC Monogr Eval Carcinog Risk Chem Hum. 1979 Dec;21:461-77.
Pituitary tumor apoplexy associated with extrapontine myelinolysis during pregnancy: A case report.
Ye W, Huang W, Chen L, Yao C, Sheng S, Liu Z, Xue C, Xing W.
Medicine (Baltimore). 2021 Mar 12;100(10):e25075. doi: 10.1097/MD.0000000000025075.
Management of pituitary tumors in pregnancy.
Bronstein MD, Paraiba DB, Jallad RS.
Nat Rev Endocrinol. 2011 May;7(5):301-10. doi: 10.1038/nrendo.2011.38. Epub 2011 Mar 15.
